Stay updated on NSCLC Progressed Anti-PD-1 Clinical Trial

Sign up to get notified when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NSCLC Progressed Anti-PD-1 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.0%
    Check dated 2026-01-17T01:24:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing California, District of Columbia, Illinois, Maryland, Massachusetts, Missouri, New York, Pennsylvania, Tennessee, Texas, Virginia, Alberta, Ontario, and Quebec; removed the previous per-state and per-province location subsections.
    Difference
    0.9%
    Check dated 2025-12-19T12:54:27.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2. This is a minor administrative update with no changes to study content or participant information.
    Difference
    0.0%
    Check dated 2025-11-27T23:46:17.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Publications text was updated to clarify that PubMed entries are automatically filled and may not pertain to the study, and the page revision is updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-20T23:12:57.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Removed the government funding status notice that appeared at the top of the page. This operational detail does not affect the study data or eligibility information on the ClinicalTrials.gov record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-13T17:11:23.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    HUDSON umbrella study overview and multiple treatment arms have been added to the Study Details page, including combinations such as Durvalumab with Olaparib, Danvatirsen, Ceralasertib, Vistusertib, Oleclumab, Trastuzumab deruxtecan, and Cediranib. A 'Results Posted' update and expanded study details and locations are also included.
    Difference
    12%
    Check dated 2025-10-30T11:30:13.000Z thumbnail image

Stay in the know with updates to NSCLC Progressed Anti-PD-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NSCLC Progressed Anti-PD-1 Clinical Trial page.